GenVec Q4 Net Loss Deepens

GenVec (NASDAQ: GNVC  ) results for the company’s Q4 and fiscal 2012 have been released. For the quarter, revenue was $1.5 million, less than half the $3.4 million of the same period the previous year. Attributable net loss deepened over that time span, to $3.2 million ($0.24 per diluted share), from Q4 2011's shortfall of $2.5 million ($0.19).

On average, analysts had anticipated revenue of $3.7 million, and a per-share loss of $0.27.

For the full year, top line was $9.5 million, far below the  2011 figure of $17.7 million. Net loss plunged further into the red, to $14.1 million ($1.09 per diluted share) for the year against 2011's $7.4 million ($0.58).


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2328220, ~/Articles/ArticleHandler.aspx, 4/19/2014 5:34:37 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement